Background: The loco regional relapse is frequent in the lung disease. The aim of this study was to evaluate the outcomes of re-irradiation by SBRT in terms of Local Control (LC) and toxicities. Methods: From April 2011 to December 2016, twenty-two patients received a re-irradiation by SBRT. Twenty- seven lesions were treated. The medium BED(10) of re-irradiation was 100.6 Gy (range: 48-151.2 Gy) and the medium EQD2(10) was 93.8 Gy (range: 40-126 Gy). In the previous treatment the medium BED(10) was 97.2 Gy (range: 40-120 Gy), the medium EQD2(10) was 81 Gy (range: 32.5-100 Gy). The median time between the first and the second treatment was 18 months. Results: Local Control was reached in 18 out of 27 (66%) re-irradiated lesions, with rates of 67 and 54% at 1- year and 2- years respectively. The treatment was well tolerated; the maximum recorded toxicity was Grade 3. Conclusions: Re- irradiation by SBRT may represent an option for the treatment of lung disease with good results in terms of LC and toxicity.

Re-irradiation in lung disease by SBRT. A retrospective, single institutional study / Caivano, D.; Valeriani, M.; De Matteis, S.; Bonome, P.; Russo, I.; De Sanctis, V.; Minniti, G.; Osti, M. F.. - In: RADIATION ONCOLOGY. - ISSN 1748-717X. - 13:1(2018), pp. 1-8. [10.1186/s13014-018-1041-y]

Re-irradiation in lung disease by SBRT. A retrospective, single institutional study

Caivano D.
;
De Matteis S.
Membro del Collaboration Group
;
Bonome P.;De Sanctis V.
Membro del Collaboration Group
;
Minniti G.;Osti M. F.
2018

Abstract

Background: The loco regional relapse is frequent in the lung disease. The aim of this study was to evaluate the outcomes of re-irradiation by SBRT in terms of Local Control (LC) and toxicities. Methods: From April 2011 to December 2016, twenty-two patients received a re-irradiation by SBRT. Twenty- seven lesions were treated. The medium BED(10) of re-irradiation was 100.6 Gy (range: 48-151.2 Gy) and the medium EQD2(10) was 93.8 Gy (range: 40-126 Gy). In the previous treatment the medium BED(10) was 97.2 Gy (range: 40-120 Gy), the medium EQD2(10) was 81 Gy (range: 32.5-100 Gy). The median time between the first and the second treatment was 18 months. Results: Local Control was reached in 18 out of 27 (66%) re-irradiated lesions, with rates of 67 and 54% at 1- year and 2- years respectively. The treatment was well tolerated; the maximum recorded toxicity was Grade 3. Conclusions: Re- irradiation by SBRT may represent an option for the treatment of lung disease with good results in terms of LC and toxicity.
2018
lung; primary or metastatic disease; re-irradiation; sbrt; adenocarcinoma; aged; aged, 80 and over; carcinoma; large cell; carcinoma; non-small-cell lung; squamous cell; female; follow-up studies; humans; lung neoplasms; male; middle aged; prognosis; radiosurgery; re-irradiation; retrospective studies; small cell lung carcinoma; survival rate
01 Pubblicazione su rivista::01a Articolo in rivista
Re-irradiation in lung disease by SBRT. A retrospective, single institutional study / Caivano, D.; Valeriani, M.; De Matteis, S.; Bonome, P.; Russo, I.; De Sanctis, V.; Minniti, G.; Osti, M. F.. - In: RADIATION ONCOLOGY. - ISSN 1748-717X. - 13:1(2018), pp. 1-8. [10.1186/s13014-018-1041-y]
File allegati a questo prodotto
File Dimensione Formato  
Caivano_Re-irradiation_2018.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 628.21 kB
Formato Adobe PDF
628.21 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1421027
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 12
social impact